ID
ACAD icon

Integral Derivatives’s Acadia Pharmaceuticals ACAD Stock Holding History

Integral Derivatives’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-13,300
Closed -$371K – 1111
2017
Q2 		$371K Buy
+13,300
New +$396K 0.01% 798
2017
Q1 		– Sell
-21,700
Closed -$626K – 1124
2016
Q4 		$626K Sell
21,700
-8,600
-28% -$228K 0.01% 655
2016
Q3 		$964K Buy
+30,300
New +$1.03M 0.02% 443
2014
Q1 		– Sell
-19,200
Closed -$480K – 1281
2013
Q4 		$480K Buy
+19,200
New +$453K 0.01% 1049

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return